Annual report pursuant to Section 13 and 15(d)

Summary of significant accounting policies (Details) - Schedule of expense related to share-based payment arrangements

v3.20.2
Summary of significant accounting policies (Details) - Schedule of expense related to share-based payment arrangements - USD ($)
$ in Thousands
12 Months Ended
Jul. 31, 2020
Jul. 31, 2019
Jul. 31, 2018
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Share Based Compensation $ 933 $ 939 $ 813
Cost of clinical laboratory services [Member]      
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Share Based Compensation 46
Selling, general and administrative [Member]      
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Share Based Compensation $ 887 $ 939 $ 813